Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-07

Clinical Trial Update: Adhesion and Safety of Rotigexole Compared to Neupro® [NA]

View source ↗

Summary

A clinical trial comparing adhesion and safety of Rotigexole vs Neupro (rotigotine patch) in idiopathic Parkinson's disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)
  • Rotigexole (rotigexole)

Snippet

Sponsor: Eva Pharma | Conditions: Idiopathic Parkinson Disease | NA | Status: NOT_YET_RECRUITING